EVENTS|NEWS|CONTACT|DONATE

Gastric Cancer
Accelerate Research
Patient Resources
Nutrition
- Eating and Healing
- Gesundheit Kitchen
  - Watch Episodes
  - Printable Recipes
Ways to Give
About Us

Read Our Newsletter

Gastric Cancer
Accelerate Research
Patient Resources
Nutrition
- Eating and Healing
- Gesundheit Kitchen
  - Watch Episodes
  - Printable Recipes
Ways to Give
About Us

Tag

h. pylori

H. Pylori and Gastric Cancer: What to Know About this Common Gut Infection

The bacterium Helicobacter pylori (H. pylori) commonly infects the stomach lining and is known to be a major risk factor for gastric...

Social Media

Newsroom

For press inquiries about the Gastric Cancer Foundation, please contact: Mediainfo@gastriccancer.org

Categories

Foundation News
Press Releases
Research News
Your New Normal

Tags

adenocarcenoma advanced stage alcohol antibody biomarker blood chemoradiotherapy chemotherapy clinical trial clinical trials detection drugs endoscopy Epstein-Barr esophagogastric FDA gastrectomy gastric cancer registry gastroesophageal genes heartburn helicobacter pylori HER2 immunotherapy keytruda lonsurf metastatic nutrition peritoneal postoperative prevention proton pump inhibitor recovery recurrence research risk screening side-effects studies surgery survival treatment tumor virus women

Gastric Cancer Foundation

Tax ID 27-2978173

info@gastriccancer.org

PO Box 6279
Albany, CA 94706

Site Map

Gastric Cancer
Accelerate Research
Patient Resources
Nutrition
- Eating and Healing
- Gesundheit Kitchen
  - Watch Episodes
  - Printable Recipes
Ways to Give
About Us

Social Feed

Gastric Cancer Foundation

1 day ago

Gastric cancer patients with targetable biomarkers like HER2 and mismatch repair can achieve long-term disease control or even cures with drugs that target these tumor abnormalities, or with immunotherapy, a recent study demonstrated. The authors commented that research advances have expanded the universe of patients who can be successfully treated without surgery. Gastric Cancer Foundation urges patients to discuss biomarker testing with their oncologists, and we remain proud supporters of the National Test Your Biomarkers campaign. ... See MoreSee Less

Complete Response, Potential Cure With Systemic Chemotherapy in Metastatic Gastric Cancer

www.medpagetoday.com

Enrichment of actionable tumor biomarkers seen in patients with long-term disease control

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Gastric Cancer Foundation

3 days ago

Gastric Cancer Foundation is proud to be hosting interns this summer who are learning abour gastric cancer and working on projects to help us support patients, raise awareness, and advance research. A big welcome to Michelle Seo, cognitive neuroscience major at UC Santa Cruz (and cellist!), Sable Zuniga, a global and community health major at UC Riverside, and Ethan Toyofuku, a high school student (and fencer!) in Mercer Island, WA. ... See MoreSee Less

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Gastric Cancer Foundation

3 days ago

Pfizer has launched a late-stage clinical trial of a novel bispecific antibody that targets both PD‑1 and VEGF in patients with gastric cancer. The distinctive design of the drug engages the immune system to fight cancer, while simultaneously choking off the blood supply to tumors. Pfizer will investigate the impact of adding the drug to chemotherapy. For more information or to enroll at one of the many U.S. sites participating in the trial, click here: clinicaltrials.gov/study/NCT07392892. ... See MoreSee Less

ClinicalTrials.gov

clinicaltrials.gov

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Gastric Cancer Foundation

1 week ago

Cleveland Clinic has embarked on a new effort to boost the early diagnosis of gastrointestinal cancers, including stomach cancer, through a combination of improved screening, education and research. We applaud this effort, as early detection is key to improving outcomes in gastric cancer! ... See MoreSee Less

How Cleveland Clinic’s Gastrointestinal Cancer Program Is Working to Reshape Screening, Care and Outcomes

consultqd.clevelandclinic.org

A new program looks to innovative approaches for advancing early detection and multicancer prevention.

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Gastric Cancer Foundation

1 week ago

Do gastric cancer patients benefit from more chemotherapy before surgery? Here’s what a team of researchers at Moffitt Cancer Center found. ... See MoreSee Less

Do Gastric and Esophageal Cancer Patients Benefit From More Chemotherapy Before Surgery?

www.moffitt.org

Moffitt study shows patients who receive more treatment before surgery may responded better

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Subscribe to Our Newsletter

We’ll deliver our monthly newsletter to your Inbox with Foundation updates, news about cutting edge research and trends in the field, and how to make a difference.

© 2024 Gastric Cancer Foundation. All Rights Reserved.

EVENTS | NEWS | CONTACT | DONATE

X